Cadence Neuroscience

Cadence Neuroscience is a medical device company based in Redmond, Washington, founded in 2017. The company focuses on developing innovative implantable neuromodulation therapies aimed at treating epilepsy and other neurological disorders, particularly drug-resistant epilepsy. Their core technology, initially developed at Mayo Clinic, is currently undergoing clinical evaluation. It is designed to detect specific brain signals and deliver targeted electrical stimulation to modulate neural circuits, with the goal of improving treatment outcomes. Cadence is dedicated to enhancing the lives of individuals with epilepsy, especially children, who often face challenges in accessing effective treatments. The company emphasizes patient-centered innovation by collaborating with clinicians and families to ensure that its therapies are safe and effective. Their implantable neuromodulation device aims to reduce or eliminate seizures in patients with refractory epilepsy, while their flexible system is tailored to meet individual patient needs for long-term management. Cadence Neuroscience is committed to providing alternatives to traditional surgical and medication-based treatments for pediatric epilepsy patients.

• Employees20
• Founded2018
• Annual Revenue$4000000
• Total Funding$483539892